Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
70.0%
% of PJP's 30 holdings also in IHE
56.8%
% of IHE's 38 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.1% | 22.8% | 5.1% |
|
ELI LILLY & CO | 4.7% | 22.7% | 4.7% |
|
PFIZER INC | 4.9% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 5.0% | 4.3% | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.9% | 4.6% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to IHE
|
ABBVIE INC | 5.2% |
|
GILEAD SCIENCES INC | 5.2% |
|
AMGEN INC | 5.0% |
|
ABBOTT LABORATORIES | 5.0% |
|
BIOSANTE PHARMACEUTICALS INC | 3.0% |
|
TARSUS PHARMACEUTICALS, INC. | 2.8% |
|
BIOGEN IDEC INC | 2.7% |
|
TRAVERE THERAPEUTICS, INC. | 2.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.5% |
|
REGENERON PHARMACEUTICALS | 2.5% |
PJP Underweight Relative to IHE
|
ELI LILLY & CO | -18.0% |
|
JOHNSON & JOHNSON | -17.7% |
|
ZOETIS INC | -4.6% |
|
INTRA-CELLULAR THERAPIES INC | -4.6% |
|
ROYALTY PHARMA PLC CLASS A | -4.3% |
|
ELANCO ANIMAL HEALTH, INC. | -2.1% |
|
VIATRIS, INC. | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -2.0% |
|
BRISTOL-MYERS SQUIBB CO | -1.7% |
|
ORGANON & CO. | -1.6% |